Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.

Jelcić I, Hsu KC, Kakalacheva K, Breiden P, Dupont B, Uhrberg M, Martin R, Münz C, Lünemann JD.

Mult Scler. 2012 Jul;18(7):951-8. doi: 10.1177/1352458511431726. Epub 2011 Dec 20.

PMID:
22185807
2.

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF.

Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695.

PMID:
19630074
3.

Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.

Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, You L, Chen ZJ, Li JF, Zhao YR.

J Clin Immunol. 2008 Jul;28(4):343-9. doi: 10.1007/s10875-008-9183-6. Epub 2008 Feb 23.

PMID:
18297378
4.

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.

Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M.

Cancer Immunol Immunother. 2005 Feb;54(2):172-8. Epub 2004 Jul 10.

PMID:
15248031
5.

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y.

Clin Immunol. 2010 Oct;137(1):139-46. doi: 10.1016/j.clim.2010.05.011.

PMID:
20643584
6.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

7.

Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.

Hirayasu K, Ohashi J, Kashiwase K, Hananantachai H, Naka I, Ogawa A, Takanashi M, Satake M, Nakajima K, Parham P, Arase H, Tokunaga K, Patarapotikul J, Yabe T.

PLoS Pathog. 2012;8(3):e1002565. doi: 10.1371/journal.ppat.1002565. Epub 2012 Mar 8.

8.

Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population.

Zhuang YL, Ren GJ, Tian KL, Li XY, Zhu YB, Liu JL, Si GL, Li P, Zhang Y, Wang L, Zhang WJ, Wang DJ, Zhu CF.

APMIS. 2012 Oct;120(10):828-35. doi: 10.1111/j.1600-0463.2012.02911.x. Epub 2012 May 7.

PMID:
22958291
9.

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.

Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I, Grzybowska E.

Hum Immunol. 2014 Jun;75(6):508-13. doi: 10.1016/j.humimm.2014.04.002. Epub 2014 Apr 19.

PMID:
24755350
10.

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.

Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaëlsson J.

Blood. 2010 Feb 11;115(6):1166-74. doi: 10.1182/blood-2009-09-245746. Epub 2009 Nov 10.

11.

Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.

Charoudeh HN, Schmied L, Gonzalez A, Terszowski G, Czaja K, Schmitter K, Infanti L, Buser A, Stern M.

Immunogenetics. 2012 Oct;64(10):739-45. doi: 10.1007/s00251-012-0633-1. Epub 2012 Jul 7.

PMID:
22772778
12.

Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.

Salim PH, Jobim M, Bredemeier M, Chies JA, Schlottfeldt J, Brenol JC, Jobim LF, Xavier RM.

Clin Exp Immunol. 2010 Jun;160(3):325-30. doi: 10.1111/j.1365-2249.2010.04095.x. Epub 2010 Jan 15.

13.

Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.

Keating SE, Ní Chorcora C, Dring MM, Stallings RL, O'Meara A, Gardiner CM.

Tissue Antigens. 2015 Sep;86(3):172-7. doi: 10.1111/tan.12608. Epub 2015 Jul 22.

PMID:
26202659
14.

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Senitzer D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.

Hum Immunol. 2010 Aug;71(8):804-8. doi: 10.1016/j.humimm.2010.05.011. Epub 2010 May 17.

PMID:
20483367
15.

Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.

David G, Djaoud Z, Willem C, Legrand N, Rettman P, Gagne K, Cesbron A, Retière C.

J Immunol. 2013 Nov 1;191(9):4778-88. doi: 10.4049/jimmunol.1301580. Epub 2013 Sep 27.

16.

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

Jiao YL, Zhang BC, You L, Li JF, Zhang J, Ma CY, Cui B, Wang LC, Chen ZJ, Zhao YR.

J Clin Immunol. 2010 Nov;30(6):840-4. doi: 10.1007/s10875-010-9444-z. Epub 2010 Jul 21.

PMID:
20652381
17.

Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.

García-León JA, Pinto-Medel MJ, García-Trujillo L, López-Gómez C, Oliver-Martos B, Prat-Arrojo I, Marín-Bañasco C, Suardíaz-García M, Maldonado-Sanchez R, Fernández-Fernández O, Leyva-Fernández L.

Mol Immunol. 2011 Sep;48(15-16):1896-902. doi: 10.1016/j.molimm.2011.05.018. Epub 2011 Jun 12.

PMID:
21665278
18.

KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.

Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.

Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c.

PMID:
23478359
19.

Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.

Littera R, Chessa L, Onali S, Figorilli F, Lai S, Secci L, La Nasa G, Caocci G, Arras M, Melis M, Cappellini S, Balestrieri C, Serra G, Conti M, Zolfino T, Casale M, Casu S, Pasetto MC, Barca L, Salustro C, Matta L, Scioscia R, Zamboni F, Faa G, Orrù S, Carcassi C.

PLoS One. 2016 Jan 8;11(1):e0146086. doi: 10.1371/journal.pone.0146086. eCollection 2016.

20.

Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.

Hilton HG, Guethlein LA, Goyos A, Nemat-Gorgani N, Bushnell DA, Norman PJ, Parham P.

J Immunol. 2015 Oct 1;195(7):3160-70. doi: 10.4049/jimmunol.1501358. Epub 2015 Aug 26.

PMID:
26311903
Items per page

Supplemental Content

Write to the Help Desk